Loading organizations...
Loading organizations...
Developing transformative pharmaceutical therapies for emerging markets.
Everest Medicines has raised $310.0M across 1 funding round.
Everest Medicines has raised $310.0M in total across 1 funding round.
Everest Medicines has raised $310.0M in total across 1 funding round.
Everest Medicines's investors include Hillhouse Capital, John Ho, Jiashan SDIC, RA Capital Management, Wei Fu, Cormorant Asset Management, Decheng Capital, GT Fund, HBM Healthcare Investments, Janus Henderson Investors, Octagon Capital, Pavilion Capital.
Everest Medicines has raised $310.0M across 1 funding round. Most recently, it raised $310.0M Series C in June 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 5, 2020 | $310.0M Series C | Hillhouse Capital, John Ho, Jiashan SDIC, RA Capital Management | Wei Fu, Cormorant Asset Management, Decheng Capital, GT Fund, HBM Healthcare Investments, Janus Henderson Investors, Octagon Capital, Pavilion Capital, Rock Springs Capital |